Clinical Trial Update: Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer [NA]

View source ↗

Summary

This clinical trial is evaluating dual PSMA and FDG PET imaging for patients with advanced prostate cancer, and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Advanced Prostate Cancer | NA | Status: RECRUITING